drugset / Trial / NCT02782286

Morphine Versus Ketorolac in Low Back Pain

NCT02782286

Phase 4 Unknown 100 enrolled Loredana Ghinea
RandomizedCrossoverTriple-blindTreatment

Summary

The study is prospective, double blinded, randomised controlled and has the purpose to compare the analgesic effects of ketorolac or morphine intravenous in low back pain.

Timeline

Start
2016-05
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 30 mg Intravenous
Comparator Morphine Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.